Abstract
Background While guidelines recommend focusing primarily on stroke risk to recommend anticoagulants in atrial fibrillation (AF), physicians report that geriatric syndromes (e.g., falls, disability) are important when considering anticoagulants. Little is known about the prevalence of geriatric syndromes in older adults with AF or the association with anticoagulant use.
Methods We performed a cross-sectional analysis of the 2014 Health and Retirement Study, a nationally representative study of older Americans. Participants were asked questions to assess domains of aging, including function, cognition, and medical conditions. We included participants ≥65 years with two years of continuous Medicare enrollment who met AF diagnosis criteria by claims codes. We examined five geriatric syndromes: one or more falls within the last two years, receiving help with activities of daily living (ADL) or instrumental activities of daily living (IADL), experienced incontinence, and cognitive impairment. We determined the prevalence of geriatric syndromes and their association with anticoagulant use adjusting for ischemic stroke risk (i.e., CHA2DS2-VASc score).
Results In this study of 779 participants with AF (median age 80 years, median CHA2DS2-VASc score 4), 82% had ≥1 geriatric syndrome. Geriatric syndromes were common: 49% reported falls, 38% had ADL impairments, 42% had IADL impairment, 37% had cognitive impairments, and 43% reported incontinence. Overall, 65% reported anticoagulant use; guidelines recommend anticoagulant use for 97% of participants. Anticoagulant use rate decreased for each additional geriatric syndrome (average marginal effect −3.7%; 95% CI −1.4% to −5.9%). Lower rates of anticoagulant use were reported in participants with ADL dependency, IADL dependency, and dementia.
Conclusion Most older adults with AF had at least one geriatric syndrome, and geriatric syndromes were associated with reduced anticoagulant use. The high prevalence of geriatric syndromes may explain the lower than expected anticoagulant use in older adults.
Competing Interest Statement
MCF reports grants from NIH/NHLBI, during the conduct of the study. SEG and KEC report grants from NIH/NIA, during the conduct of the study. SJS reports grants from NIH/NCATS, during the conduct of the study. No financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Funding Statement
This study was supported by the National Center for Advancing Translational Sciences (KL2TR001870), the National Institute on Aging (P30AG044281 and P30AG015272), and the National Heart Lung and Blood Institute (K24HL141354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data sharing: Researchers can apply to use the Health and Retirement Study (hrs.isr.umich.edu/) for access to the data use in this study. Code used to generate the cohort and perform the analyses can be found on Dryad.